Amado S, Simões M J, Armada da Silva P A S, Luís A L, Shirosaki Y, Lopes M A, Santos J D, Fregnan F, Gambarotta G, Raimondo S, Fornaro M, Veloso A P, Varejão A S P, Maurício A C, Geuna S
Faculty of Human Kinetics (FMH), Technical University of Lisbon (UTL), Lisbon, Portugal.
Biomaterials. 2008 Nov;29(33):4409-19. doi: 10.1016/j.biomaterials.2008.07.043. Epub 2008 Aug 23.
Many studies have been dedicated to the development of scaffolds for improving post-traumatic nerve regeneration. The goal of this study was to develop and test hybrid chitosan membranes to use in peripheral nerve reconstruction, either alone or enriched with N1E-115 neural cells. Hybrid chitosan membranes were tested in vitro, to assess their ability in supporting N1E-115 cell survival and differentiation, and in vivo to assess biocompatibility as well as to evaluate their effects on nerve fiber regeneration and functional recovery after a standardized rat sciatic nerve crush injury. Functional recovery was evaluated using the sciatic functional index (SFI), the static sciatic index (SSI), the extensor postural thrust (EPT), the withdrawal reflex latency (WRL) and ankle kinematics. Nerve fiber regeneration was assessed by quantitative stereological analysis and electron microscopy. All chitosan membranes showed good biocompatibility and proved to be a suitable substrate for plating the N1E-115 cellular system. By contrast, in vivo nerve regeneration assessment after crush injury showed that the freeze-dried chitosan type III, without N1E-115 cell addition, was the only type of membrane that significantly improved posttraumatic axonal regrowth and functional recovery. It can be thus suggested that local enwrapping with this type of chitosan membrane may represent an effective approach for the improvement of the clinical outcome in patients receiving peripheral nerve surgery.
许多研究致力于开发用于改善创伤后神经再生的支架。本研究的目的是开发和测试用于周围神经重建的混合壳聚糖膜,其可单独使用或富含N1E-115神经细胞。对混合壳聚糖膜进行体外测试,以评估其支持N1E-115细胞存活和分化的能力,并在体内评估其生物相容性,以及评估其对标准化大鼠坐骨神经挤压伤后神经纤维再生和功能恢复的影响。使用坐骨神经功能指数(SFI)、静态坐骨神经指数(SSI)、伸肌姿势推力(EPT)、退缩反射潜伏期(WRL)和踝关节运动学来评估功能恢复。通过定量体视学分析和电子显微镜评估神经纤维再生。所有壳聚糖膜均显示出良好的生物相容性,并被证明是接种N1E-115细胞系统的合适基质。相比之下,挤压伤后的体内神经再生评估表明,未添加N1E-115细胞的冻干III型壳聚糖膜是唯一能显著改善创伤后轴突再生和功能恢复的膜类型。因此,可以认为用这种类型的壳聚糖膜进行局部包裹可能是改善接受周围神经手术患者临床结局的有效方法。